BeStock  

Morgan Stanley MS

US equityMarket cap rank #51Capital MarketsAsset Management
$181.44 −$1.00 (-0.55%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $181.80 +0.20%
Open$182.40
Prev close$182.44
Day range$181.36 – $185.34
Volume6.02M
Market cap$283.60B
P/E (TTM)14.4
Dividend yield2.29%

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-1.8%BearishTrading below the 20-day average of $184.68
Price vs 50-day average-7.0%BearishTrading below the 50-day average of $195.16
Price vs 200-day average-6.1%BearishTrading below the 200-day average of $193.32
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)42.4BearishMomentum leans negative
MACD (12,26,9)-2.27BullishMACD line is above its signal line
Bollinger band position30%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$184.68-1.8%
50-day SMA$195.16-7.0%
200-day SMA$193.32-6.1%

Recent price levels

LevelPrice
20-day high$196.97
20-day low$176.44
60-day high$220.53
60-day low$176.44
Upper Bollinger band$192.81
Lower Bollinger band$176.54

The 50-day average is currently 1.0% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility32.4%
Average true range3.33% of price
Max drawdown (1y)-21.5%
Volume (10d vs 90d)1.23x

Discussion

No comments yet — be the first to weigh in on MS.

Leave a comment

Scroll to Top